Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study
Jonathan P. Piccini, Anders Ahlsson, Paul Dorian, Marc A. Gillinov, Peter R. Kowey, Michael J. Mack, Carmelo A. Milano, Louis P. Perrault, Jonathan S. Steinberg, Nathan H. Waldron, Maxwell Adams, David B. Bharucha, Mitchell F. Brin, William Ferguson, Stefano Benussi
Topics & Concepts
MedicineClinical endpointAtrial fibrillationCardiac surgeryPlaceboIntensive care unitSurgeryRandomized controlled trialIncidence (geometry)Internal medicineCardiologyOpticsPhysicsAlternative medicinePathologyAtrial Fibrillation Management and OutcomesCardiac and Coronary Surgery TechniquesBotulinum Toxin and Related Neurological Disorders